Invitro Specialitylab Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -53.88%
- Profit Growth -156.59%
- Ebitda -65.39%
- Net Worth -63.96%
- Total Assets 4.12%
About Invitro Specialitylab
Invitro Specialitylab Private Limited (ISPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2017 (Seven years and seven months 17 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rameshchandra Shah, Naresh Laddha, Ilesh Patel, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2017PTC098050
-
Company No.
098050
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Invitro Specialitylab?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ilesh Patel
|
Director | 04-Jul-2017 | Current |
|
Rameshchandra Shah
|
Director | 27-Jun-2017 | Current |
|
Naresh Laddha
|
Director | 27-Jun-2017 | Current |
Chiragbhai Patel
|
Director | 13-Jul-2018 | Current |
Financial Performance of Invitro Specialitylab.
Invitro Specialitylab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.88% decrease. The company also saw a substantial fall in profitability, with a 156.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invitro Specialitylab?
Unlock access to Invitro Specialitylab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ingress Bio Solutions Private LimitedNaresh Laddha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invitro Specialitylab?
Invitro Specialitylab has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invitro Specialitylab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invitro Specialitylab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
